|
|
|
|
|
Session 88
Poster Abstracts Construction and Evaluation of Vaccine Strategies Wednesday, 1:30 - 3:30 pm Hall D |
Background: Clostridium
perfringens
has been engineered to express high levels of SIV antigenic
protein for delivery to the mouse terminal ileum. Dendritic
cells (DC) resident in Peyer’s patches (PP) in the terminal
ileum are key mediators in mucosal immune response development. Thus, it is
imperative that protein delivery via C. perfringens has the capacity to stimulate DC to mature
and prime T cells.
Methods: A modified
pJRC200 vector with the cytotoxic regions of the cpe gene replaced by the SIV p27 gene was electroporated into C.
perfringens
to create bacteria producing high levels of p27. Bone marrow-derived DC
(BMDC) and murine PP tissues were exposed to lysates of sporulating cultures
of recombinant bacteria expressing p27, bacteria carrying a control plasmid, or
media alone for 2 to 4 hours. BMDC and PP tissue sections were subjected to immunofluoresence staining using α-CD11c and
α-p27 antibodies for the detection of DC and p27, respectively. The fate
of internalized p27 was monitored by Western blot analysis with α-p27
serum. CD80, CD86, CD40, MHC class II, and internalized dextran
were detected on/in CD11c-positive DC using flow cytometry.
ELISA were performed to measure IL-12, IL-10, and
TNF-α. T-cell reactivity was assessed by IFN-γ ELISpot
and CD107a and b flow cytometry.
Results: BMDC and
Conclusions: These data
demonstrate that SIV p27 delivered via our recombinant C. perfringens can be taken up and processed by immature
DC. Maturation of DC is stimulated in response to the vaccine. In addition,
mature DC stimulate IFN-γ-producing and cytolytically
active p27-specific T cells. These results show that DC can mediate the
formation of an immune response against SIV p27 when exposed to the C. perfringens vaccine in vitro and suggest that DC
will mediate strong responses in vivo following oral immunization.
Keywords: Clostridium perfringens; dendritic cell; immunity
![]() |